DK35389A - Pyrazin, pyridazin- eller pyrimidinforbindelse - Google Patents

Pyrazin, pyridazin- eller pyrimidinforbindelse

Info

Publication number
DK35389A
DK35389A DK035389A DK35389A DK35389A DK 35389 A DK35389 A DK 35389A DK 035389 A DK035389 A DK 035389A DK 35389 A DK35389 A DK 35389A DK 35389 A DK35389 A DK 35389A
Authority
DK
Denmark
Prior art keywords
pyridazine
pyrazine
pyrimidine compound
pyrimidine
compound
Prior art date
Application number
DK035389A
Other languages
Danish (da)
English (en)
Other versions
DK35389D0 (da
Inventor
Raymond Baker
John Saunders
Leslie J Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888802101A external-priority patent/GB8802101D0/en
Priority claimed from GB888815225A external-priority patent/GB8815225D0/en
Priority claimed from GB888817812A external-priority patent/GB8817812D0/en
Priority claimed from GB888821088A external-priority patent/GB8821088D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of DK35389D0 publication Critical patent/DK35389D0/da
Publication of DK35389A publication Critical patent/DK35389A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK035389A 1988-01-30 1989-01-27 Pyrazin, pyridazin- eller pyrimidinforbindelse DK35389A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888802101A GB8802101D0 (en) 1988-01-30 1988-01-30 Therapeutic agents
GB888815225A GB8815225D0 (en) 1988-06-27 1988-06-27 Therapeutic agents
GB888817812A GB8817812D0 (en) 1988-07-26 1988-07-26 Therapeutic agents
GB888821088A GB8821088D0 (en) 1988-09-08 1988-09-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
DK35389D0 DK35389D0 (da) 1989-01-27
DK35389A true DK35389A (da) 1989-07-31

Family

ID=27450036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK035389A DK35389A (da) 1988-01-30 1989-01-27 Pyrazin, pyridazin- eller pyrimidinforbindelse

Country Status (10)

Country Link
EP (1) EP0327155A3 (fr)
JP (1) JPH02111768A (fr)
KR (1) KR890011860A (fr)
AU (1) AU622141B2 (fr)
DK (1) DK35389A (fr)
FI (1) FI890419A7 (fr)
IL (1) IL89034A0 (fr)
NO (1) NO890364L (fr)
NZ (1) NZ227684A (fr)
PT (1) PT89523B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
US5177084A (en) * 1989-08-08 1993-01-05 Merck Sharp & Dohme Ltd. Therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes
GB8918060D0 (en) * 1989-08-08 1989-09-20 Merck Sharp & Dohme Therapeutic agents
EP0413545B1 (fr) * 1989-08-16 1997-05-14 Beecham Group Plc Composés azabicycliques
GB9005737D0 (en) * 1990-03-14 1990-05-09 Beecham Group Plc Novel compounds
DK72790D0 (da) * 1990-03-21 1990-03-21 Ferrosan As Heterocycliske forbindelser, deres fremstilling og anvendelse
GB9017353D0 (en) * 1990-08-08 1990-09-19 Merck Sharp & Dohme Chemical process
CA2050264A1 (fr) * 1990-08-30 1992-03-01 Raymond Baker Pyrazine a substitution et ses sels, compositions qui en contiennent et leur utilite en medecine
EP0492903A1 (fr) * 1990-12-21 1992-07-01 MERCK SHARP &amp; DOHME LTD. Pyrazines, pyrimidines et pyridazines substitués utiles dans le traitement de glaucome
EP0492902A1 (fr) * 1990-12-21 1992-07-01 MERCK SHARP &amp; DOHME LTD. Pyridines substitués utiles dans le traitement de glaucome
GB9201749D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Plc Medicaments
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU672644B2 (en) * 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU1141497A (en) * 1995-11-29 1997-06-19 Eli Lilly And Company Heterocyclic compounds and their use
US5889019A (en) * 1995-11-29 1999-03-30 Eli Lilly And Company Heterocyclic compounds and their use
US5834458A (en) * 1996-10-09 1998-11-10 Eli Lilly And Company Heterocyclic compounds and their use
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
EP0978280A1 (fr) * 1997-04-26 2000-02-09 Sumitomo Pharmaceuticals Company, Limited Composes 2-azabicyclo
PL365238A1 (en) * 2000-02-16 2004-12-27 Neurogen Corporation Substituted arylpyrazines
US20060025468A1 (en) * 2004-07-29 2006-02-02 Whitten Jeffrey P Chiral pyrrolidine derivatives, and methods for preparing compounds thereof
JP2007032031A (ja) * 2005-07-25 2007-02-08 Sanyo Industries Ltd 持出し手摺構造及びその取付け方法
WO2019028440A1 (fr) 2017-08-04 2019-02-07 Skyhawk Therapeutics, Inc. Méthodes et compositions permettant de moduler l'épissageé
WO2020163248A1 (fr) * 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Procédés et compositions pour moduler l'épissage
WO2020163382A1 (fr) * 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Procédés et compositions pour moduler l'épissage
EP3920915A4 (fr) 2019-02-05 2022-10-05 Skyhawk Therapeutics, Inc. Procédés et compositions pour moduler l'épissage
CN114126613A (zh) 2019-02-05 2022-03-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
CN113661162A (zh) 2019-02-06 2021-11-16 斯基霍克疗法公司 用于调节剪接的方法和组合物
WO2020163544A1 (fr) 2019-02-06 2020-08-13 Skyhawk Therapeutics, Inc. Procédés et compositions pour moduler l'épissage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911710A (fr) * 1972-05-15 1974-02-01
CA1244028A (fr) * 1983-04-14 1988-11-01 Hans Maag Derives de pyrimidine
ZA842595B (en) * 1983-04-14 1985-11-27 Hoffmann La Roche Pyrimidine derivatives
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
AU614513B2 (en) * 1987-04-15 1991-09-05 Beecham Group Plc 1-azabicyclic compounds
CA2000041A1 (fr) * 1988-10-13 1990-04-13 Barry S. Orlek Composes

Also Published As

Publication number Publication date
EP0327155A3 (fr) 1992-01-02
FI890419A7 (fi) 1989-07-31
PT89523B (pt) 1994-02-28
NO890364L (no) 1989-07-31
KR890011860A (ko) 1989-08-23
DK35389D0 (da) 1989-01-27
PT89523A (pt) 1989-10-04
AU2883489A (en) 1989-08-03
FI890419A0 (fi) 1989-01-27
EP0327155A2 (fr) 1989-08-09
JPH02111768A (ja) 1990-04-24
IL89034A0 (en) 1989-08-15
NO890364D0 (no) 1989-01-27
NZ227684A (en) 1991-07-26
AU622141B2 (en) 1992-04-02

Similar Documents

Publication Publication Date Title
DK35389D0 (da) Pyrazin, pyridazin- eller pyrimidinforbindelse
NO904511L (no) Pyrimidiner.
MX9202838A (es) Imidazo[1,5-a]quinoxalinas.
FI830708A7 (fi) 1,2,4-triatsiini- ja pyratsiinijohdannaiset.
NO872961L (no) Pyrimidinderivater.
ATE79614T1 (de) Substituierte pyrimidine.
DE69201748D1 (de) Pyrazinderivate.
DE68910447D1 (de) Pyridazinonderivate.
DE3584032D1 (de) Substituierte pyridazine.
DK151172C (da) Moebel, saasom sidde- eller liggemoebel
AU4707689A (en) Phenylsulfamoyl-1,2,4-triazolo(1,5-a)pyrimidines
FI871123A7 (fi) Pyrazolo/3,4-d/pyrimidinderivat, deras framstaellning och anvaendning.
DE69110093D1 (de) Pyrimidinderivate.
DE3889362D1 (de) Substituierte 1,2,4-Triazolo[1,5-a]triazine als Bronchodilatatoren.
FI20000354L (fi) Perhydro-1H-pyrido/1,2-a/pyratsiinijohdannaiset
NO882233L (no) Pyrimidinderivater.
NO873362L (no) Pyrimidinderivater.
DE3884347D1 (de) Pyrimidinderivate.
DE3776011D1 (de) 2-substituierte alkoxy-3-substituierte pyrazine.
DE58907080D1 (de) Phenylpyridine.
FI912963L (fi) Hjaernverksamheten oekande pyrimidinylderivat.
ATE54401T1 (de) Fungizide pyridazine.
DE3862197D1 (de) (2-cyano-2-(phenyl oder naphthyl)-2-substituierte aethyl)pyrazine, pyrimidine und pyridazine.
ES552126A0 (es) Mueble de asiento.
FI880430L (fi) Pilokarpinderivat.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment